沃森生物

- 300142

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
沃森生物(300142) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入411,377.23315,804.44216,767.1383,326.74508,644.52
营业收入411,377.23315,804.44216,767.1383,326.74508,644.52
二、营业总成本315,221.33232,086.84152,614.4466,153.95380,622.33
营业成本59,755.6245,126.3627,256.6712,484.7160,946.88
营业税金及附加3,202.602,537.271,971.251,161.883,325.10
销售费用151,957.55114,335.2478,304.6530,503.44202,216.99
管理费用29,762.3718,062.6512,089.545,823.3427,142.00
财务费用-7,099.33-5,318.92-3,526.25-1,710.24-6,298.09
研发费用77,642.5357,344.2336,518.5917,890.8293,289.45
资产减值损失----------
公允价值变动收益-23,475.01-6,738.89-1,765.29-119.29-19,933.49
投资收益711.45629.46632.84-26.771,179.69
其中:对联营企业和合营企业的投资收益38.21-43.78-40.40-21.57-107.39
汇兑收益----------
三、营业利润61,396.6177,931.1663,205.5521,447.86109,943.99
加:营业外收入93.5193.3291.324.8813.00
减:营业外支出1,592.47602.38494.49379.552,910.47
其中:非流动资产处置损失----------
四、利润总额59,897.6577,422.1162,802.3821,073.19107,046.52
减:所得税费用8,765.147,699.176,547.461,242.7913,223.88
五、净利润51,132.5169,722.9456,254.9119,830.4093,822.64
归属于母公司所有者的净利润41,939.0255,337.6545,523.9817,199.0972,865.20
少数股东损益9,193.4914,385.2910,730.932,631.3120,957.43
六、每股收益
基本每股收益(元/股)0.26210.34580.28440.10740.4546
稀释每股收益(元/股)0.26210.34580.28440.10740.4544
七、其他综合收益--------85.00
八、综合收益总额51,132.5169,722.9456,254.9119,830.4093,907.64
归属于母公司所有者的综合收益总额41,939.0255,337.6545,523.9817,199.0972,950.20
归属于少数股东的综合收益总额9,193.4914,385.2910,730.932,631.3120,957.43
下载全部历史数据到excel中 返回页顶